Yanchik Connealy Pamela Insider Trades

Insider Trading History

Track insider trading activity for Yanchik Connealy Pamela. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Health Sciences Acquisitions 2
Health Sciences Acquisitions 2 HSAQ
Director
Holding Value $10.1k 758 shares
Last Trade
Apr 12, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.1k 758 shares
$13.31
$13.31
Health Sciences Acquisitions 2
Health Sciences Acquisitions 2 HSAQ
Director
Holding Value $56.5k 4,246 shares
Last Trade
Apr 12, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$10.1k 758 shares
$13.31
$13.31
Pyxis Oncology
Pyxis Oncology PYXS
CFO And COO
Holding Value $0 0 shares
Last Trade
Mar 24, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$22.8k 10,304 shares
$2.21
$1.71
Pyxis Oncology
Pyxis Oncology PYXS
CFO And COO
Holding Value $1.02M 594,313 shares
Last Trade
Mar 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$735k 332,569 shares
$2.21
$1.71
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Director
Holding Value $92.8k 23,250 shares
Last Trade
Jan 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.99
Health Sciences Acquisitions 2
Health Sciences Acquisitions 2 HSAQ
Director
Holding Value $309k 23,250 shares
Last Trade
Jan 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$603k 45,338 shares
$13.31
$13.31
Orchestra BioMed Holdings
Orchestra BioMed Holdings OBIO
Director
Holding Value $0 0 shares
Last Trade
Jan 26, 2023 Sale
No data
No data
$3.99
Pyxis Oncology
Pyxis Oncology PYXS
Chief Financial Officer
Holding Value $658k 384,510 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60k 43,493 shares
$1.38
$1.71
Pyxis Oncology
Pyxis Oncology PYXS
Chief Financial Officer
Holding Value $583k 341,017 shares
Last Trade
Apr 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$341k 93,493 shares
$3.65
$1.71
Pyxis Oncology
Pyxis Oncology PYXS
Director, Chief Financial Officer
Holding Value $423k 247,524 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 247,524 shares
$4.04
$1.71
Pyxis Oncology
Pyxis Oncology PYXS
Chief Financial Officer
Holding Value $90.5k 52,944 shares
Last Trade
Dec 06, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$510k 52,944 shares
$9.64
$1.71
Pyxis Oncology
Pyxis Oncology PYXS
Director, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Oct 07, 2021 Sale
No data
No data
$1.71
Immunovant
Immunovant IMVT
Chief Financial Officer
Holding Value $5.29M 162,000 shares
Last Trade
Mar 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.54M 208,200 shares
$17.00
$32.67
Immunovant
Immunovant IMVT
Chief Financial Officer
Holding Value $5.9M 180,500 shares
Last Trade
May 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.43M 180,500 shares
$19.01
$32.67
Immunovant
Immunovant IMVT
Chief Financial Officer
Holding Value $14.2M 433,588 shares
Last Trade
Dec 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.02M 433,588 shares
$13.88
$32.67

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up